ClinicalTrials.Veeva

Find clinical trials for Lymphoma in Montréal, QC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Lymphoma
Leukemia
Non-Hodgkin Lymphoma
Lymphoid Leukemia
Diffuse Large B-Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Cell Chronic Lymphocytic Leukemia

Lymphoma trials near Montréal, QC, CAN:

IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas

pharmacokinetics and pharmacodynamics of IKS03, a CD19 targeting antibody-drug conjugate, in patients with advanced B cell non-Hodgkin lymphoma...

Enrolling
B-cell Non-Hodgkin Lymphoma
B-cell Lymphoma
Drug: IKS03

Phase 1

Iksuda Therapeutics

Montréal, Quebec, Canada and 2 other locations

TrAVeRse is a multicentre, open-label, randomised, Phase II study of AVR in treatment naïve MCL participants. The primary objective will be to assess...

Enrolling
Mantle Cell Lymphoma (MCL)
Drug: Venetoclax
Drug: Rituximab

Phase 2

AstraZeneca
AstraZeneca

Montreal, Quebec, Canada and 47 other locations

treatment of advanced classical Hodgkin lymphoma(HL)...

Active, not recruiting
Hodgkin Lymphoma
Drug: brentuximab vedotin
Drug: bleomycin

Phase 3

Takeda
Takeda

Montreal, Quebec, Canada and 215 other locations

purpose of this study is to assess the objective response rate of parsaclisib treatment in participants with relapsed or refractory follicular lymphoma...

Active, not recruiting
Lymphoma
Drug: Parsaclisib

Phase 2

Incyte
Incyte

Montreal, Quebec, Canada and 82 other locations

A Phase 2 study to evaluate the efficacy of nanatinostat in combination with valganciclovir in patients with relapsed/refractory EBV-positive lymphomas...

Enrolling
EBV Associated Lymphoma
EBV Related Non-Hodgkin's Lymphoma
Drug: Nanatinostat in combination with valganciclovir

Phase 2

Viracta Therapeutics

Montréal, Quebec, Canada and 93 other locations

The purpose of this study is to find out if lenalidomide when given along with rituximab can help to control the disease and also increase the length...

Active, not recruiting
Follicular Lymphoma
Drug: Rituximab - CHOP
Drug: Lenalidomide

Phase 3

The Lymphoma Academic Research Organisation

Montreal, Quebec, Canada and 34 other locations

in adult participants with Relapsed or Refractory Non-Hodgkin's Lymphoma (R/R NHL).The study will be conducted in 2 parts: Part A, monothera...

Active, not recruiting
Lymphoma, Non-Hodgkin
Drug: CC-96673

Phase 1

Celgene
Celgene

Montreal, Quebec, Canada and 12 other locations

This Phase 3 multinational, randomized, double-blind study is designed to compare the efficacy and safety of the combination of ibrutinib and venetoc...

Active, not recruiting
Mantle-Cell Lymphoma
Drug: Ibrutinib
Drug: Venetoclax

Phase 3

Pharmacyclics
Pharmacyclics

Montréal, Quebec, Canada and 119 other locations

The purpose of this study is to evaluate the efficacy of loncastuximab tesirine (ADCT-402) combined with rituximab compared to standard immunochemoth...

Enrolling
Relapsed Diffuse Large B-Cell Lymphoma
Refractory Diffuse Large B-Cell Lymphoma
Drug: Oxaliplatin
Drug: Gemcitabine

Phase 3

ADC Therapeutics

Montréal, Canada and 140 other locations

This is a global Phase 2, open-label, single-arm, multicohort, multicenter study to evaluate efficacy and safety of JCAR017 in adult subjects with r/...

Active, not recruiting
Lymphoma, Non-Hodgkin
Drug: Fludarabine
Drug: JCAR017

Phase 2

Celgene
Celgene

Montreal, Quebec, Canada and 37 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems